您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。[世界卫生组织]:脊髓灰质炎过渡战略框架:监测与评价指标元数据 - 发现报告

脊髓灰质炎过渡战略框架:监测与评价指标元数据

AI智能总结
查看更多
脊髓灰质炎过渡战略框架:监测与评价指标元数据

Monitoring and evaluationIndicator metadata Polio transitionstrategic framework Monitoring and evaluationIndicator metadata Strategic outcome 1.National immunization programmessystematically reach and immunize everyone with polio andother vaccines. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1 Contents Strategic outcome 2.National surveillance systems rapidlydetect and report poliovirus and other diseases. . . . . . . . . . . . . . .4 Strategic outcome 3.National health emergency systemsprepare for and respond to polio and other disease outbreaks.9 Strategic outcome 4.Poliovirus materials are safely andsecurely contained in line with established biorisk managementstandards. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .14 Milestone 1.Polio essential functions are safeguarded by WHOand its partners (intermediate transition). . . . . . . . . . . . . . . . . . . .16 Milestone 2.The action plan is jointly developed. . . . . . . . . . . . .20 Milestone indicator 2.2.Checklist. . . . . . . . . . . . . . . . . . . . . . . . . . .22 Milestone 3.The national government is managing polioessential functions as part of the national health system. . . . . .24 Milestone 4.Polio essential functions are predictably andsustainably funded through national budgets. . . . . . . . . . . . . . . .29 Abbreviations andacronyms AFPCDCcVDPVDTP3e-SPARGPEIIA2030IHRIMIPVM&EmOPV2nOPV2OPVPEFsPOLISR1SIAsSPARtOPVUNICEFWHOWPV acute flaccid paralysisUnited States Centers for Disease Control and Preventioncirculating vaccine-derived poliovirusdiphtheria– tetanus–pertussis vaccine, third doseElectronic States Parties Self-Assessment Annual Reporting toolGlobal Polio Eradication InitiativeImmunization Agenda 2030International Health Regulationsinfectious materialinactivated polio vaccinemonitoring and evaluationmonovalent oral polio vaccine type 2novel oral polio vaccine type 2oral polio vaccinepoliovirus-essential facilitiesPolio Information Systemlarge scale campaign Round 1supplementary immunization activitiesStates Parties Self-Assessment Annual Reporting tooltrivalent oral polio vaccineUnited Nations Children’s FundWorld Health Organizationwild poliovirus Strategic outcome 1.National immunization programmes systematically reach andimmunize everyone with polio and other vaccines Strategic outcome 1.National immunization programmes systematically reach andimmunize everyone with polio and other vaccines Strategic outcome 1.National immunization programmes systematically reach andimmunize everyone with polio and other vaccines Strategic outcome 4.Poliovirus materials are safely and securely contained in linewith established biorisk management standards Strategic outcome 4.Poliovirus materials are safely and securely contained in linewith established biorisk management standards